THE SYNTHESIS OF 3-SPIROOXINDOLE DERIVATIVES. IV. THE CONVERSION OF

DOI: 10.1248/cpb.11.1195

Source and publish data:

Chemical and pharmaceutical bulletin p. 1195 - 1197 (1963)

Update date:2022-08-11

Topics:

Authors:

OISHI OISHI

MAENO MAENO

BAN BAN

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.11.1195

Full text of DOI:10.1248/cpb.11.1195

NII-Electronic Library Service

Products guided by the article

Product name:1,2,3,4,6,7,12,12b-Octahydro-12-methylindolo[2,3-a]quinolizine

Cas No:13233-45-9

R&D Labs maybe for 13233-45-9

Shenyang Mole pharmaceutical Technology Development Co.,Ltd

Contact:+86-24-31204918/13889278616

Address:No.44, wanliutang road, shenhe District of Shenyang
Nantong Chem-land Co., Ltd.

Contact:86 513 85512619

Address:Rm.1306, Building A, Wenfeng Mansion,168 Gongnong Road, Nantong Jiangsu China
Zhejiang Newfine Industry Co.,Ltd.

Contact:+86-573-82262042

Address:No.225,Dongqing Road, garoms@163.com
Nanjing Norris Pharm Technology Co., Ltd.

Contact:+86-13901585132

Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Hebei Lead Bio-Chemicals Co., Ltd.

website:http://www.ldbiochem.com

Contact:+86-311-87826503

Address:481, Heping West Road, Shijiazhuang,China

Relevant to this article

Arylamide derivatives as peptidomimetic inhibitors of calmodulin

Doi:10.1021/ol052478j
(2006)
Temperature dependence of the Raman spectrum of 1-(4-chlorophenyl)-3-(2-thienyl)prop-2-en-1-one

Doi:10.1016/j.saa.2017.02.051
(2017)
Subtype-selective nicotinic receptor antagonists: Potential as tobacco use cessation agents

Doi:10.1016/j.bmcl.2003.10.073
(2004)
Doi:10.1016/S0040-4039(01)93639-1
(1979)
Doi:10.1007/BF01378869
(1915)
An avenue to the sordarin core adaptable to analog synthesis

Doi:10.1021/ol701547r
(2007)

Article Doi